Shares of Venture Life Group plc (LON:VLG - Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 58.07 ($0.78) and traded as high as GBX 60 ($0.80). Venture Life Group shares last traded at GBX 60 ($0.80), with a volume of 342,987 shares changing hands.
Venture Life Group Trading Down 2.4%
The firm has a market capitalization of £76.83 million, a P/E ratio of -24,000.00, a price-to-earnings-growth ratio of 5.67 and a beta of 0.30. The company has a debt-to-equity ratio of 28.45, a quick ratio of 1.48 and a current ratio of 2.22. The firm has a 50 day moving average price of GBX 58.31 and a two-hundred day moving average price of GBX 49.13.
Venture Life Group (LON:VLG - Get Free Report) last released its quarterly earnings data on Monday, June 30th. The company reported GBX 3.96 earnings per share (EPS) for the quarter. Venture Life Group had a return on equity of 0.99% and a net margin of 1.44%. On average, equities research analysts expect that Venture Life Group plc will post 6.1391542 EPS for the current fiscal year.
Insiders Place Their Bets
In other Venture Life Group news, insider Jerry Randall bought 50,000 shares of the business's stock in a transaction on Wednesday, July 2nd. The shares were bought at an average cost of GBX 59 per share, for a total transaction of £29,500. Insiders own 6.77% of the company's stock.
Venture Life Group Company Profile
(
Get Free Report)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.
With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.
Featured Articles
Before you consider Venture Life Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Venture Life Group wasn't on the list.
While Venture Life Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
